Skip to main content
. 2021 Sep 24;22(19):10280. doi: 10.3390/ijms221910280

Figure 2.

Figure 2

Active CTX was unable to modify the mLECs to allow more cancer cell adhesion in vitro. (a) A schematic of the in vitro cancer cell-mLEC adhesion assay. (b) Shown is a representative mLEC purity determined by CD31 positivity via flow cytometry. (c) Quantification of tGFP-MVT1 cells per well (in 96-well plates) adhered to mLECs pre-treated with 4-hydroperoxy-cyclophosphamide (4-OOH) (+) or vehicle (−) (n = 6 from 2 independent experiments). Bars indicate mean ± SEM; Student’s t test.